ATE202112T1 - Neue sulfatierte lyso-gangliosidederivate - Google Patents

Neue sulfatierte lyso-gangliosidederivate

Info

Publication number
ATE202112T1
ATE202112T1 AT94911404T AT94911404T ATE202112T1 AT E202112 T1 ATE202112 T1 AT E202112T1 AT 94911404 T AT94911404 T AT 94911404T AT 94911404 T AT94911404 T AT 94911404T AT E202112 T1 ATE202112 T1 AT E202112T1
Authority
AT
Austria
Prior art keywords
gangliosides
lyso
sulfonyl
poly
dilyso
Prior art date
Application number
AT94911404T
Other languages
English (en)
Inventor
Aurelio Romeo
Gunter Kirschner
Carlo Chizzolini
Hari Manev
Laura Facci
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Application granted granted Critical
Publication of ATE202112T1 publication Critical patent/ATE202112T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT94911404T 1993-03-04 1994-03-04 Neue sulfatierte lyso-gangliosidederivate ATE202112T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93PD000044A IT1267955B1 (it) 1993-03-04 1993-03-04 Derivati solfatati dei lisogangliosidi
PCT/US1994/001966 WO1994020516A1 (en) 1993-03-04 1994-03-04 New sulfated lyso-ganglioside derivatives

Publications (1)

Publication Number Publication Date
ATE202112T1 true ATE202112T1 (de) 2001-06-15

Family

ID=11390208

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94911404T ATE202112T1 (de) 1993-03-04 1994-03-04 Neue sulfatierte lyso-gangliosidederivate

Country Status (9)

Country Link
EP (1) EP0688331B1 (de)
JP (1) JPH08507308A (de)
AT (1) ATE202112T1 (de)
AU (1) AU685787B2 (de)
CA (1) CA2157357A1 (de)
DE (1) DE69427468T2 (de)
ES (1) ES2157257T3 (de)
IT (1) IT1267955B1 (de)
WO (1) WO1994020516A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1238346B (it) * 1989-11-14 1993-07-13 Gangliosidi modificati e loro derivati funzionali.
JPH03246297A (ja) * 1990-02-22 1991-11-01 Nippon Koutai Kenkyusho:Kk ガングリオシド誘導体及びこれを含有する抗ｈｉｖ剤
IT1253832B (it) * 1991-08-01 1995-08-29 Fidia Spa Derivati di gangliosidi
IT1267956B1 (it) * 1993-03-04 1997-02-18 Fidia S P A In Amministrazione Derivati o-solfatati di gangliosidi e lisogangliosidi

Also Published As

Publication number Publication date
ES2157257T3 (es) 2001-08-16
WO1994020516A1 (en) 1994-09-15
JPH08507308A (ja) 1996-08-06
DE69427468T2 (de) 2002-04-18
EP0688331A1 (de) 1995-12-27
IT1267955B1 (it) 1997-02-18
DE69427468D1 (de) 2001-07-19
AU685787B2 (en) 1998-01-29
AU6393594A (en) 1994-09-26
ITPD930044A1 (it) 1994-09-04
EP0688331B1 (de) 2001-06-13
CA2157357A1 (en) 1994-09-15
ITPD930044A0 (it) 1993-03-04

Similar Documents

Publication Publication Date Title
ATE211467T1 (de) 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung
ATE210127T1 (de) 6-substituierte mycophenolsäurederivate mit immun suppressiver wirkung
NO981436L (no) Farmas÷ytiske angiostatiske dipeptidsammensetninger og anvendelse derav
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
DE69226369D1 (de) System mit erhöhender Hautpenetration für verbesserte topische Verabreichung von Arzneimitteln
ES2114616T5 (es) Acidos dicarboxilicos alifaticos insaturados.
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
DE69637050D1 (de) Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer
FI940375A0 (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
DK0527879T3 (da) Synergistiske terapeutiske præparater og fremgangsmåder.
DE3650358D1 (de) Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis.
RU94041224A (ru) Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
FI893681A0 (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
FI894995A7 (fi) Järjestelmä vilpin estämiseksi taksamittarin käytössä
DE69427468D1 (de) Neue sulfatierte lyso-gangliosidederivate
SE9400524L (sv) Energipreparat
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DK0572549T3 (da) Behandling af ikke-småcellet lungecarcinom
ATE181669T1 (de) Verwendung von remacemid zur behandlung des morbus parkinson
NZ268039A (en) Use of efaroxan in treating parkinson's disease
IT8620027A0 (it) Tripeptide ad attivita'immunostimolante.
ES2114170T3 (es) Peptidos con actividad organo-protectora, su procedimiento de preparacion y su utilizacion en la terapia.
FR2679565B1 (fr) Analogues de l'hirudine, leur procede de preparation et leur application en therapeutique.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties